Updated July 2026. Vaccines targeting drugs of abuse remain investigational. Anti-nicotine vaccines: NicVAX and NIC7-001 failed pivotal trials; no candidate currently in advanced development. Anti-opioid vaccines: NIDA-funded fentanyl vaccine at University of Houston (Phase 1 initiated 2024, NCT06001099), oxycodone vaccine (Minnesota), heroin vaccine (Scripps/Walter Reed) — all Phase 1 or preclinical. Anti-cocaine vaccine: TA-CD (Cornell) — Phase 2 showed antibody titers correlated with reduced cocaine use in ~40% of vaccinees but not overall efficacy; development stalled. Anti-methamphetamine: IXT-m200 (InterveXion) — Phase 1. The field faces persistent challenges around inducing sufficient antibody titers, duration, and the reality that individuals may switch substances if one is blocked. Fentanyl and opioid vaccines have received substantial 2024–2026 federal funding via NIDA's HEAL Initiative in response to the opioid crisis.

Comprehensive tracking of addiction vaccine development for cocaine, opioids (heroin, fentanyl, oxycodone), methamphetamine, and other substances. Overdose crisis: 107,000+ US deaths 2021, predominantly opioids (75,000+ fentanyl deaths). Vaccines induce antibodies binding drugs in bloodstream, preventing BBB crossing, blocking reward/euphoria. Active immunization targets: TA-CD (cocaine), dAd5GNE (cocaine), heroin conjugate vaccines, fentanyl vaccines, methamphetamine vaccines in Phase 1-2 trials. Conjugate vaccine approach (drug hapten + carrier protein + adjuvant). Challenges: high drug doses overwhelming antibodies, individual response variability, polydrug use. Novel strategies: nanoparticle platforms, monoclonal antibodies (passive), combination with MAT (methadone, buprenorphine, naltrexone) and behavioral interventions. Preclinical: alcohol, cannabis vaccines.

🚨 OVERDOSE CRISIS - PUBLIC HEALTH EMERGENCY:

Drug overdose deaths reached 107,622 in 2021 (up from 70,630 in 2019) - deadliest year on record. Opioids account 80,000+ deaths (75% of total): synthetic opioids (fentanyl) 71,000 deaths, heroin 9,000, prescription opioids 16,000. Stimulants: methamphetamine 32,000 deaths (often combined with fentanyl), cocaine 24,000. Fentanyl crisis: 50-100x more potent than morphine, 2 mg lethal dose, contaminating drug supply (pressed pills, heroin, cocaine). 46 million Americans had substance use disorder 2021. Economic burden: $600+ billion annually (healthcare, criminal justice, lost productivity). Current treatments limited: Opioid Use Disorder (OUD) - only 20% receive MAT (methadone, buprenorphine), high relapse rates (40-60% within year), stigma barriers. Stimulant Use Disorder - NO FDA-approved medications, behavioral therapy only (modest efficacy). Vaccines offer revolutionary pharmacological approach: blocking drug from reaching brain receptors, reducing overdose risk (sequestering lethal doses peripherally), relapse prevention (making drug use unrewarding), adjunct to MAT/behavioral therapy.

💊 Substance Addiction Vaccine Tracker Dashboard

Addiction Vaccines by Development Phase